Form 8-K - Current report:
SEC Accession No. 0001140361-24-035233
Filing Date
2024-08-01
Accepted
2024-08-01 11:15:31
Documents
16
Period of Report
2024-08-01
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K ef20033414_8k.htm   iXBRL 8-K 27028
2 EXHIBIT 99.1 ef20033414_ex99-1.htm EX-99.1 390961
6 image0.jpg GRAPHIC 24775
7 image1.jpg GRAPHIC 1135
  Complete submission text file 0001140361-24-035233.txt   614417

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA ions-20240801.xsd EX-101.SCH 3874
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE ions-20240801_lab.xml EX-101.LAB 21966
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE ions-20240801_pre.xml EX-101.PRE 16050
18 EXTRACTED XBRL INSTANCE DOCUMENT ef20033414_8k_htm.xml XML 4056
Mailing Address 2855 GAZELLE COURT CARLSBAD CA 92010
Business Address 2855 GAZELLE COURT CARLSBAD CA 92010 7609319200
IONIS PHARMACEUTICALS INC (Filer) CIK: 0000874015 (see all company filings)

EIN.: 330336973 | State of Incorp.: CA | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-19125 | Film No.: 241165092
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)